Lymphocyte-predominant Hodgkin's disease in clinical stage IA: Interim analysis of treatment options in three study generations of the German Hodgkin study group (GHSG).

被引：0
|
作者：
Nogova, L
Reineke, T
Josting, A
Brillant, C
Eich, H
Wingbermuehle, K
Behringer, K
Diehl, V
Engert, A
机构：
[1] Univ Hosp Cologne, Clin Radiotherapy, Cologne, Germany
[2] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
82
引用
收藏
页码：26A / 27A
页数：2
相关论文
共 50 条
  • [1] Treatment options for lymphocyte-predominant Hodgkin's disease (LPHD) in clinical stage IA: Review of the German Hodgkin Study Group (GHSG).
    Engert, A
    Nogova, L
    Josting, A
    Brillant, C
    Reineke, T
    Eich, H
    Mueller, RP
    Diehl, V
    BLOOD, 2002, 100 (11) : 570A - 571A
  • [2] Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    Behringer, Karolin
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2014, 124 (21)
  • [3] Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Schroeder, Lena
    Fuchs, Michael
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2016, 128 (22)
  • [4] Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Fuchs, Michael
    Pluetschow, Annette
    Klimm, Beate
    Halbsguth, Teresa
    Boell, Boris
    von Tresckow, Bastian
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2011, 118 (21) : 1166 - 1167
  • [5] Lymphocyte-predominant Hodgkin's disease - An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group
    vonWasielewski, R
    Werner, M
    Fischer, R
    Hansmann, ML
    Hubner, K
    Hasenclever, D
    Franklin, J
    Sextro, M
    Diehl, V
    Georgii, A
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (03): : 793 - 803
  • [6] Lymphocyte-predominant and classical Hodgkin's lymphoma:: A comprehensive analysis from the German Hodgkin study group
    Nogova, Lucia
    Reineke, Thorsten
    Brillant, Corinne
    Sieniawski, Michal
    Ruediger, Thomas
    Josting, Andreas
    Bredenfeld, Henning
    Skripnitchenko, Roman
    Mueller, Rolf-Peter
    Mueller-Hermelink, Hans-Konrad
    Diehl, Volker
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 434 - 439
  • [7] The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
    Hartmann, Sylvia
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Mottok, Anja
    Bob, Roshanak
    Koch, Karoline
    Bernd, Heinz-Wolfram
    Cogliatti, Sergio
    Hummel, Michael
    Feller, Alfred C.
    Ott, German
    Moeller, Peter
    Rosenwald, Andreas
    Stein, Harald
    Hansmann, Martin-Leo
    Engert, Andreas
    Klapper, Wolfram
    BLOOD, 2013, 122 (26) : 4246 - 4252
  • [8] Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Fuchs, Michael
    Pluetschow, Annette
    Klimm, Beate
    Halbsguth, Teresa
    Boell, Boris
    Von Tresckow, Bastian
    Nogova, Lucia
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2011, 118 (16) : 4363 - 4365
  • [9] Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG)
    Hartmann, Sylvia
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Mottok, Anja
    Bob, Roshanak
    Koch, Karoline
    Bernd, Heinz-Wolfram
    Cogliatti, Sergio
    Hummel, Michael
    Feller, Alfred C.
    Ott, German
    Moeller, Peter
    Rosenwald, Andreas
    Stein, Harald
    Hansmann, Martin-Leo
    Engert, Andreas
    Klapper, Wolfram
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 238 - 242
  • [10] Comparison of patients (Pts) characteristic and treatment outcomes in lymphocyte-predominant (LPHD) and classical Hodgkin's disease (cHD): A report from the German Hodgkin Lymphoma Study Group (GHSG).
    Nogova, L
    Reineke, T
    Josting, A
    Behringer, K
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 368A - 369A
12345